Prospera Energy (PEI.V)’s big corporate evolution: From incompetence to dishonesty
Brera Holdings (BREA.Q) pioneering pubco sports investment model, but is it a win?
“The markets are dead!”: Emerita Resources (EMO.V) shows otherwise with massive upside coming
Lithium Ionic (LTH.V) is up 50% in 3 months, and is moving toward production
Digital Twinning, and how EdgeTI (CTRL.V) is a serious story you’ve never heard of
Bionxt Solutions (BNXT.C): Seeking to confirm national-level cancer drug patent
Cybin (CYBN.NE) has selected social anxiety disorder (SAD) and generalized anxiety disorder (GAD) as the targets for their CYB004 proprietary psychedelic molecule. Read full article here: https://equity.guru/2021/06/16/cybin-cybn-ne-selects-sad-and-gad-as-targets-for-their-cyb004-psychedelic-molecule/
